Population‐based genetic testing for cancer susceptibility genes: quo vadis?

doi:10.1111/1471-0528.17283

Article

Population‐based genetic testing for cancer susceptibility genes: quo vadis?

26 Aug 2022

Abstract excerpt

Ovarian cancer (OC), breast cancer (BC), endometrial cancer (EC) and colorectal cancer (CRC) account for approximately 50% of cancers in women.1 A total of 2.9 million women worldwide and approximately 88 000 women in the UK are diagnosed with these cancers annually, and 1.05 million women worldwide and 25 000 women in the UK die from them per year.1, 2 GLOBOCAN predicts that the number of these cancer cases will...

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.